CVSCVS Health
Price
+19%1YEnd-of-day closes, not the intraday tick.
A mixed picture: the questions disagree
Quality mixed, nothing alarming, price roughly fair, growth steady, the market undecided.
CVS Health Corporation, together with its subsidiaries (collectively, “CVS Health,” the “Company,” “we,” “our” or “us”), is a leading health solutions company building a world of health around every consumer it serves and connecting care so that it works for people wherever they are. As of December 31, 2025, we had approximately 9,000 retail locations, more than 1,000 walk-in and primary care medical clinics and a leading pharmacy benefits manager with approximately 87 million plan members and expanding specialty pharmacy solutions.
In the company’s own words · 10-K filed Feb 10, 2026 · SEC EDGAR
Charts
As reported to the SEC, without any scoring.
CVS Health (CVS) reported revenue of $106.1B in Q2 2026 (quarter ended Jun 30, 2026), up 7.3% from the same quarter a year earlier. That came with a gross margin of 45% and net income of $2.98B (2.8% of revenue). For the full year FY2025, revenue was $402.1B (+7.8% year on year) and net income $1.77B. Its largest segment in Q2 2026 was Health Services at $51.8B, 42% of the disclosed total, ahead of Health Care Benefits at 30%. The next results filing is expected around Oct 28, 2026, the same week as a year ago.
What the company said
The company's own words from its current reports to the SEC, newest first
- Aug 17, 2026On August 13, 2026, Larry M. Robbins notified the Board of Directors (the “Board”) of CVS Health Corporation (the “Company”) of his resignation from the Board, effective immediately.Director or officer change · Form 8-K
- Aug 5, 2026Second quarter total revenues increased to $106.1 billion, up 7.3% year-over-year.Earnings release · press release
- May 18, 2026On May 14, 2026, CVS Health Corporation (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”)Director or officer change · Form 8-K
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
Business segments
Q2 2026 · $123.30BThe company’s own SEC segment disclosure.
- Health Services$51.80B42%
- Health Care Benefits$37.54B30%
- Pharmacy And Consumer Health$33.82B27%
- Corporate And Other$147.0M0%
Why these answers
Each answer with the checks it was read from. Open one for the numbers.
Conflicts between checks are named, never averaged, and thin data says so.